P-glycoprotein (P-gp) acts as a transmembrane pump that can facilitate the removal of anti-cancer agents by utilizing energy released from ATP hydrolysis, and P-gp overexpression plays a significant role in the development of multidrug resistance (MDR) in tumors (Shen et al., 2020). Here, PGP is linked to cancer.